迪安诊断：多重扰动下常规ICL增长稳健，看好下半年政策缓和下业绩回升

多重扰动下常规 ICL 增长稳健，看好下半年政策缓和下业绩回升 迪安诊断（300244）/医疗器械 证券研究报告/公司点评 2024 年 8 月 26 日 [Table_Industry] | --- | --- | --- | --- | --- | --- | --- | |---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|----------------------------------------------------------------------------------------------------------------------- ...